Summary. The perfused pancreas was used for kinetic studies of leucine and phenylalanine induced insulin secretion. In a glucose-free medium, leucine stimulated insulin release over a wide range (5--80 mM). Substimulatory levels of glucose (3 raM) potentiated the leucine induced insulin release. At higher glucose concentrations (20 mM), the rate of leueine-provoked insulin release was not further enhanced. Phenylalanine (5--80 raM) did not provoke significant insulin secretion, either in the presence or in the absence of 3 mM glucose.
Naturally occuring as well as synthetic, nonmetabolizable amino acids are insulin stimulators [1--4] . However amino acids differ markedly in their insulin releasing capacities both in vivo and in vitro [1, 5--7] . Investigations of the metabolism of certain amino acids suggested that amino acid induced insulin release is not due to the fact that they serve as fuels for the islets of Langerhans [9] . On the basis of transport studies it has been proposed that amino acids provoke insulin release by binding to specific receptors [2] . Using the isolated rat pancreas, we have investigated the dynamics of insulin secretion in response to leucinc and phenylalanine at various concentrations and in different combinations with glucose. It is suggested that the results present further evidence for the importance of direct receptor sites in amino acid induced insulin release.
Materials and Methods
Material. All reagents were of analytical grade. Dextran (MW 60,000--80,000), purchased from Knoll AG, Ludwigshafen, Germany, was dialyzed against twice distilled water to remove traces of contaminating glucose. D-glucose, L-Leueine and L-phenylalanine were obtained from Merck AG, Darmstadt.
Methods. D-glucose in dialyzed dextran was measured by an enzymatic fluorometrie assay [10] . Insulin in the perfusate was determined by the immunoassay of Hales and Randle [11] , using human insulin as the standard. The insulin concentrations are therefore expressed as equivalents of human insulin. The radioimmunoassay was not affected by low or high concentrations of leucine or phenylalanine.
Male Sprague-Dawley rats, 150--300 g and fed ad libitum with Altromin| chow and water, were used as pancreas donors. After an overnight fast, the animals were injected intraperitoneally with atropine (0.15 mg/kg body weight) and anesthetized with pentobarbital (55 mg/kg body weight). The pancreas, with the adjacent stomach, spleen and proximal part of the duodenum, was removed. The celiac axis and the portal vein were cannulated and the tissue was then placed in a perfusion apparatus at a temperature of 35--37~ The perfusion system used was a modification of that described by Sussman et al. [8] . The perfusate was not allowed to recycle.
The perfusion fluid consisted of: NaC1, 120 mM; KC1, 4.7 mM; MgSO 4, 0.8 mM; CaCI 2, 2.5 mM; KH~PO 4 1.2 mM, and NaHC03, 25 mM. Dialyzed Dextran (8%) was added to provide a colloid osmotic pressure comparable to that of plasma. The perfusate was prewarmed to 37~ and equilibrated with O2:C02 (95:5) and finally adjusted with HC1 to a pH of 7.4. During a perfusion period of 10--20 rain the flow rate was adjusted to 5 ml/min resulting in a perfusion pressure of 60--80 mm Hg in the arterial cannula. At the end of this stabilization period three samples were taken as controls. At zero time the stimulatory period was started by switching a three-way valve from the control solution to the stimulatory perfusion fluid. A very small dead space in the connecting tubing at the arterial and venous side provided a rapid change, which was completed within seconds.
The effluent was sampled for seven seconds at time intervals indicated in the figures. After sampling the samples were stored frozen at --20~ until used.
Results
The secretion kinetics shown in the following figures and represent mean curves with their standard errors. It has to be stressed that the individual insulin patterns of different animals are qualitatively reproducible, but vary with respect to the amounts of insulin secreted. The quantitative differences in insulin release to the same stimulus between different animals could not be related to the basal secretion rate of these animals. We therefore did not compute the relative insulin responses (increment in insulin release divided by the basal insulin secretion • 100) [12] .
Leucine-Induced Insulin Release a) Dose-dependent Insulin Secretion due to Leucine.
In a glucose-free medium the secretory response to 5--80 mE leucine was biphasic and dose-dependent ( Fig. 1, 2) . A linear relationship was observed between the leucine concentration up to 20 mM and the initial (Fig. 2 ). In the second secretory phase the dependency of the hormone release on leucine concentration was characterized by a sigmoidal curve. Biphasic secretion due to leucine has also been described by Basabe et al. [13] .
A remarkable phenomenon was observed when the pancreas was stimulated twice. The second stimulatory period was started after 20 min of perfusion with control medium. The second stimulation caused an insulin output that was much greater than that observed during the first stimulation. We will refer to this phenomenon as "priming" in analogy with a similar and previous described effect of glucose [14] [15] [16] .
b) The Influence of Glucose on Leucine.Induced Insulin Release. In the presence of a substimulatory concentration of glucose (3 raM), leucine (10 and 20 mM) provoked secretion kinetics comparable to those induced by equimolar concentrations of leucine alone (Fig. 1) . However, in the presence of 3 mM glucose the effect of leucine was significantly greater iD both phases and was almost identical to that produced by equimolar glucose (Fig. 3) . Obviously, 3 mM glucose changed the beta cell sensitivity to leucine,
with 20 mM glucose plus 20 mM leucine (Fig. 4) . These data may suggest that leucine had no influence on the beta cell sensitivity for glucose. Comparable results were published by Levin et al. [17] The stimulation of the beta cell with 20 mM glucose plus 10 or 20 mM leucine also resulted in biphasic secretion profiles (Fig. 4 , shown for 20 mM leucine). When one compares the kinetic pattern induced by leucine plus 3 mM glucose with that of leucine plus 20 mM glucose, it is obvious, that the high glucose concentrations had no significant additional effect.
No priming was noted upon restimulation with 20 mM leucine plus 20 mM glucose. c) Influence of Preperfusion with Leucine on the Subsequent Response to Glucose and Leucine. Superimposing 20 mM glucose on a 20 mM leucine stimulation led to a significant enhancement of insulin secretion in a biphasic manner (Fig. 5) . However the total amount of insulin released was not larger than the amount of insulin released during direct stimulation 20 mM leucine plus 20 mM glucose was not greater than with 20 m~ leueine plus 3 mM glucose (Fig. 3) .
Preperfusion of 20 mM leucine followed by 40 mM leucine resulted in a moderate further enhancement of secretion (not shown).
Phenylalanine-Induced Insulin Release
In the absence of glucose, phenylalanine (10 and 20 raM) did not provoke significant insulin secretion (Fig. 6) . When a substimulatory level of glucose (3 mM) was present, a variable concentration independent and delayed monophasic increase of insulin release was noted (Fig. 6) . Neither with nor without 3 mM glucose could a priming effect be observed upon restimulation with phenylalanine. The removal of phenylalanine led to a marked and, up to 20 mM In order to test whether in fact phenylalanine inhibited insulin release, 10 mM phenylalanine was superimposed on a 20 mSI glucose stimulus (Fig. 7) . Immediately after the addition of phenylalanine, inhibition of insulin release occurred. However, this inhibition was only transient and was followed by an increase in the release rate. In these experiments, the discontinuation of perfusion with phenylalanine led to a slight fall in the rate of insulin output but not to an "off-effect". could be released upon restimulation leading to the priming effect. A similar phenomenon might also occur during leueine stimulation. However one can also argue, that this hypersensitivity upon restimulation is caused by temporarily lasting membrane receptor changes due to previous receptor binding or insulin release 
Discussion
At low concentrations of leueine only a small and delayed initial phase of insulin release could be observed. Increasing concentrations of leueine not only enhanced the rapidity of onset and the rate of release during the initial phase, but also led to a second phase of secretion. Using pieces of rabbit pancreas Milner [6] found a linear relationship between the rate of insulin secretion and ]eueine concentration in the range 0--12.5 mM during a 30 rain incubation. Similarily, a linear dose-response relationship was observed in our experiments with glucose-free medium during the first phase of release (0--10 rain) up to 20 mM leucine. In the second phase (10--40 rain), however, a sigmoid dose-response curve was obtained with maximum stimulation above 20 mM leucine. Lernmark obtained similar results studying isolated islets of obese hyperglycemic mice [18] .
The hyperresponsiveness of the beta cell ("priming") noted when prolonged leucine stimulation was followed by a short rest period and restimulation is not well understood. Applying a threshold distribution hypothesis for packet storage of insulin, Grodsky [15] suggested that after prolonged stimulation with high glucose a still unknown agent continues to provide additional insulin into a labile compartment in the absence of the stimulus. This "overfilled" compartment
The limitation of the hypersensitivity in time could be shown for glucose : After a rest period of forty minutes no priming could be detected (unpublished data).
The rate of insulin release due to leucine (10 and 20 raM) was potentiated by 3 mM glucose. The possibility that glucose could activate leucine metabolism in the beta cell and thereby enhance the secretory response to leueine is unlikely, since Hellman et al. [9] found an inhibitory action of glucose on leucine oxidation. Moreover, maximum teucine oxidation was observed with as little as 5 mM amino acid and the rate of oxidation of leucine, arginine and alunine did not correlate with the ability of these amino acids to induce insulin secretion. From these data it was concluded that amino acids do not act as insulin seeretagogues by serving as fuels for the beta cell.
Although the role of glucose in connection with leueine induced insulin secretion is obscure, it is conceivable that glucose may enhance the affinity of a beta cell receptor for leueine through eonformational changes of the beta cell membrane. Such an effect would be possible, if glucose and leueine receptors are located closely enough at the beta cell membrane, so that the activation of one would lead to eonformational changes of the other, making it more accessible. However the only receptors for leucine that have as yet been identified in the beta cell plasma membrane are the systems A and L for transport of neutral s 1%. Landgraf et al. : Insulin Release and D-Glucose with Perfused Rat Pancreas ami~o acids [3, 19] . It is noteworthy therefore that glucose does not affect leucine uptake by microdisseeted islets of obese-hyperglycemic mice [3] .
Phenylalanine was not able to provoke marked insulin release in the presence or in the absence of substimulatory levels of glucose. From the fact that phenylalanine is an essential amino acid and is incorporated into the insulin molecule we conclude that it has to be transported into the beta cell. Therefore transport of an amino acid may not be sufficient for stimulating insulin release. This view was also stressed by }tellman et al. [3] . They found for example uptake of alanine [3] and D-leueine [19] into mouse islets without insulin secretion.
The dose-dependent "off-effect" after removal of phenylalanine is only demonstrable in the presence of substimulatory levels of glucose. This phenomenon seems to be specific for certain compounds (for example phcnylalanine, glucosamine [20] and fatty acids [21]), and is not due to rapid changes in perfusion flow or pressure or changes in the osmotic pressure of the medium. The absence of the "off-effect" with 80 mM phenylalanine could be due to irreversible alterations in the islets at this high concentration. It is reasonable to assume, that the rapid release which occurs as a consequence of the removal of phenylalanine is due to a de-inhibition. However it is interesting to note, that during phenylalanine perfusion no inhibition of the basal secretion rate occured. An inhibitory effect could only be demonstrated in the presence of 20 mM glucose. At this glucose concentration the inhibitory phase was quickly overcome by a short hypersecretion. Further studies are obviously necessary to identify the site at which phenylalanine exerts its inhibitory action.
In conclusion, the data support the idea that the receptor site of transport system L is not identical with the site signalling insulin release [19] . The positive or negative interactions of the two amino acids with glucose, phenomena which may not be due to metabolic events, seems to favour the concept of different receptors, which can be modified by glucose.
